FDA Pulls Avandia From Retail Shelves

Avandia, the once-popular type 2 diabetes medication that's been in steady decline since being linked to a risk of heart attack in 2007, is on its last legs in the retail market. The U.S. Food and Drug Administration (FDA) announced this week that starting in November, Avandia (and its companion rosiglitazone medicines Avandamet and Avandaryl) will no longer be available through retail pharmacies. Only a very limited number of patients will still be able to receive these drugs via mail order, and then only after meeting strict eligibility standards and enrolling in a special program.

Get the details on the Avandia announcement -- including links to FDA information -- in this blog post on the Avandia removal from the market from Nolo's Personal Injury Blog.